Skip to content
20-F

Annual Report (Foreign)

REALM THERAPEUTICS PLC

0001718903-19-000002

← back to feed
Filed
Apr 10, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Dec 31, 2018 116.56M sh
Capex FY 2018 · Dec 31, 2018 $46K
Capex FY 2018 · Dec 31, 2017 $208K
Operating Cash Flow FY 2018 · Dec 31, 2018 −$14.97M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$9.5M
Cash And Equivalents FY 2018 · Dec 31, 2018 $2.92M
Cash And Equivalents FY 2018 · Dec 31, 2017 $9.51M
Cash And Equivalents FY 2018 · Dec 31, 2016 $21.43M
Stockholders Equity FY 2018 · Dec 31, 2018 $21.34M
Stockholders Equity FY 2018 · Dec 31, 2017 $32.2M
Stockholders Equity FY 2018 · Dec 31, 2016 $19.05M
Total Liabilities FY 2018 · Dec 31, 2018 $493K
Total Liabilities FY 2018 · Dec 31, 2017 $2.91M
Current Assets FY 2018 · Dec 31, 2018 $20.31M
Current Assets FY 2018 · Dec 31, 2017 $34.54M
Total Assets FY 2018 · Dec 31, 2018 $21.84M
Total Assets FY 2018 · Dec 31, 2017 $35.11M
Sga Expense FY 2018 · Dec 31, 2018 $4.91M
Sga Expense FY 2018 · Dec 31, 2017 $3.62M
Rd Expense FY 2018 · Dec 31, 2018 $8.57M
Rd Expense FY 2018 · Dec 31, 2017 $8.19M
Net Income FY 2018 · Dec 31, 2018 −$13.63M
Net Income FY 2018 · Dec 31, 2017 −$10.52M
Operating Income FY 2018 · Dec 31, 2018 −$14.03M
Operating Income FY 2018 · Dec 31, 2017 −$10.69M
Revenue FY 2018 · Dec 31, 2018 $253K
Revenue FY 2018 · Dec 31, 2017 $1.12M